Wishing all mothers a Happy Mother's Day from Acella Pharmaceuticals. 💗💐Your strength, love, and dedication inspire us. Thank you for all you do. #MothersDay
Acella Pharmaceuticals, LLC’s Post
More Relevant Posts
-
Buy Direct with NuCare Pharmaceuticals! 🚀 For over 20 years, NuCare Pharmaceuticals has been a trusted name in the industry, and we’re excited to announce a game-changing move in the GLP-1 market! As the unprecedented GLP-1 patient demand continues with semaglutide and tirzepatide leading the charge, we're committed to offering you top-quality products at unbeatable prices. 💊✨ We source exclusively from FDA-registered manufacturers and rigorously third-party test all our products to ensure the highest standards. Unfortunately, we’ve noticed that some companies are buying our products and reselling them at inflated prices. 😠 At NuCare, we believe in integrity and value over profits. That’s why we’re cutting our prices to beat the middleman and ensure you get the best deal possible. 💰🔍 If you're a 503a or 503b pharmacy not currently buying directly from us, we urge you to make the switch. We guarantee a minimum savings of $100 per gram compared to what you’re currently paying. Let's build a long-lasting partnership where quality and savings go hand in hand. 🤝💼 Discover the NuCare difference today and experience the value we bring to the table. Visit us at https://lnkd.in/dwq2SSfw for more details and to make the switch. #Pharmaceuticals #GLP1 #Semaglutide #Tirzepatide #Integrity #Value #NuCarePharmaceuticals #API #Pharmacy
To view or add a comment, sign in
-
How are prescription drug prices determined? In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. Have you ever wondered why that little pill in your medicine cabinet costs so much? Let’s dive into the intricate world of pharmaceutical economics and uncover the factors that determine the price tags on our prescriptions. https://lnkd.in/e7XRxAyb
To view or add a comment, sign in
-
Medications like Ozempic and Mounjaro, that reputable pharmaceutical companies manufacture, help a lot of people. But there are also disreputable individuals who are trying to capitalize on counterfeit medications by making false claims that they can replicate results from the original FDA-approved medications. There have been several incidences where patients have had serious complications from these products. It’s strongly recommended that you only fill your prescriptions from licensed physicians, and not use medications from unfamiliar or unverified sources. Learn more about counterfeit diabetic medications at: bit.ly/3WmGIav #myAMCR #HeadlandsResearchAMCR #Diabetes #CounterfeitMedications #ImitationDrugs
To view or add a comment, sign in
-
Getting #RareDisease #Patients their medications when they need them is crucial. #CuraScriptSD works closely with #MedicalPractices to ensure the timely distribution of specialty pharmaceuticals for their patients. Learn more here: https://bit.ly/48yFgX3 #CaringForThoseWhoCare
To view or add a comment, sign in
-
Only put off until tomorrow what you are willing to die having left undone. ## Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea Shares of \*\*Regeneron Pharmaceuticals, Inc. \(REGN\)\*\* were down 4.63% after an unfavorable ruling in its lawsuit against \*\*Amgen \(AMGN\)\*\* in the United States District Court for the Northern District of West Virginia. The lawsuit was related to a biosimilar of its lead drug Eylea \(aflibercept 2 mg\). Regeneron's shares have rallied 24.3% so far this year, driven by strong performance in its pharmaceutical business and positive clinical trial results. However, this court ruling has led to a decline in the stock price. As an investor, it is essential to stay informed about developments that can impact your investments. Health Savings Accounts \(HSAs\) offer a unique opportunity to invest in healthcare-related companies such as Regeneron Pharmaceuticals. By effectively managing your HSA portfolio, you can potentially grow your savings while simultaneously supporting the healthcare industry. Don't miss out on the potential benefits of investing in healthcare. Act now and explore the opportunities available with your HSA. Invest in your health, your family's well-being, and secure your financial future. #hsa #investing #healthcare #health #family #wellness 💪💰🏥
Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea
zacks.com
To view or add a comment, sign in
-
Founder of Law Offices of Scott Glovsky | Skilled trial attorney | Insurance Bad Faith, Catastrophic Personal Injury, Sexual Abuse, Healthcare Litigation
The Journal of Managed Care & Specialty Pharmacy published an article predicting some of the next pharmaceutical #medications to appear on Medicare's drug negotiation list. They include medications for cancer, diabetes, GI disorders, and more. Read below. #Medicare #healthinsurance
To view or add a comment, sign in
-
In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. Have you ever wondered why that little pill in your medicine cabinet costs so much? Let’s dive into the intricate world of pharmaceutical economics and uncover the factors that determine the price tags on our prescriptions. https://lnkd.in/ek_6sUM4
To view or add a comment, sign in
-
We're kicking off day one of #DPHARM2024 with words from Patient Keynote, Sarah Zenner-Dolan, moderated by Peyton Howell, MHA, Parexel. A former pharmaceutical executive, Ms Zenner-Dolan's view of our industry was transformed after being diagnosed with Parkinson's disease and participating in a clinical trial as a patient. Learn more about the 14th annual program here: https://lnkd.in/ejMS4E7a #DPHARM2024 #pharma #patientadvocate
To view or add a comment, sign in
-
🚨 New FDA Approval 🚨 𝐓𝐡𝐞 𝐔.𝐒. 𝐅𝐃𝐀 𝐡𝐚𝐬 𝐚𝐩𝐩𝐫𝐨𝐯𝐞𝐝 𝐋𝐞𝐪𝐬𝐞𝐥𝐯𝐢 (𝐝𝐞𝐮𝐫𝐮𝐱𝐨𝐥𝐢𝐭𝐢𝐧𝐢𝐛), 𝐚𝐧 𝐨𝐫𝐚𝐥 𝐉𝐀𝐊 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫, 𝐟𝐨𝐫 𝐭𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐬𝐞𝐯𝐞𝐫𝐞 𝐚𝐥𝐨𝐩𝐞𝐜𝐢𝐚 𝐚𝐫𝐞𝐚𝐭𝐚 𝐢𝐧 𝐚𝐝𝐮𝐥𝐭𝐬 🔹 Sun Pharmaceutical Industries Limited announced that the U.S. FDA approved 𝐋𝐄𝐐𝐒𝐄𝐋𝐕𝐈 (𝐝𝐞𝐮𝐫𝐮𝐱𝐨𝐥𝐢𝐭𝐢𝐧𝐢𝐛) 8 mg tablets for the treatment of adults with severe alopecia areata 🔹 The approval is supported by two Ph3 trials (THRIVE-AA1 & THRIVE-AA2) involving 1,220 patients and two long-term studies with over 100 patients on treatment for over 3 years 🔹 Data were also collected from two open-label, long-term extension trials in which patients were eligible to enroll upon completion of the 24Wk trials 🔹 Sun Pharma is launching an access program to help eligible patients start and stay on Leqselvi, demonstrating their commitment to the alopecia areata community and enhancing patient care
To view or add a comment, sign in
5,881 followers